OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cytogenetic abnormalities in NPM1-mutated acute myeloid leukemia
Weijia Fu, Aijie Huang, Lili Xu, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2022) Vol. 63, Iss. 8, pp. 1956-1963
Closed Access | Times Cited: 6
Weijia Fu, Aijie Huang, Lili Xu, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2022) Vol. 63, Iss. 8, pp. 1956-1963
Closed Access | Times Cited: 6
Showing 6 citing articles:
Acute Myeloid Leukaemia
FRACP Barbara J. Bain MB BS, FRCP Mike Leach MB ChB
(2024), pp. 141-270
Closed Access | Times Cited: 3
FRACP Barbara J. Bain MB BS, FRCP Mike Leach MB ChB
(2024), pp. 141-270
Closed Access | Times Cited: 3
Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1‐mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party
Nour Moukalled, Myriam Labopin, Jurjen Versluis, et al.
American Journal of Hematology (2024) Vol. 99, Iss. 3, pp. 360-369
Closed Access | Times Cited: 3
Nour Moukalled, Myriam Labopin, Jurjen Versluis, et al.
American Journal of Hematology (2024) Vol. 99, Iss. 3, pp. 360-369
Closed Access | Times Cited: 3
Mutant NPM1 maintains RASGRP3 protein stability via interaction with MID1 to promote acute myeloid leukemia cell proliferation and autophagy
Youping Wang, Pan Chi, Xia Zhang, et al.
Journal of Leukocyte Biology (2023) Vol. 113, Iss. 5, pp. 504-517
Closed Access | Times Cited: 4
Youping Wang, Pan Chi, Xia Zhang, et al.
Journal of Leukocyte Biology (2023) Vol. 113, Iss. 5, pp. 504-517
Closed Access | Times Cited: 4
Clinical efficacy of azacytidine and venetoclax and prognostic impact of Tim-3 and galectin-9 in acute myeloid leukemia and high-risk myelodysplastic syndromes: A single-center real-life experience
Valentina Giudice, Bianca Serio, Idalucia Ferrara, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 4
Valentina Giudice, Bianca Serio, Idalucia Ferrara, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 4
Re-induction therapy in patients with acute myeloid leukemia not in complete remission after the first course of treatment
Weijia Fu, Yue Hu, Guihua Lu, et al.
Annals of Hematology (2023) Vol. 102, Iss. 2, pp. 329-335
Closed Access | Times Cited: 2
Weijia Fu, Yue Hu, Guihua Lu, et al.
Annals of Hematology (2023) Vol. 102, Iss. 2, pp. 329-335
Closed Access | Times Cited: 2
TG-interacting factor 1 improves risk stratification in patients with NPM1-mutated acute myeloid leukemia
Hongwei Tang, Nan Zhang, Huan Li, et al.
Advances in Clinical and Experimental Medicine (2023) Vol. 32, Iss. 7, pp. 741-751
Open Access
Hongwei Tang, Nan Zhang, Huan Li, et al.
Advances in Clinical and Experimental Medicine (2023) Vol. 32, Iss. 7, pp. 741-751
Open Access
